Mar 232016
 
 March 23, 2016  Posted by  Healthcare

Glyn Moody reports:

Recently, we wrote about how Sage Bionetworks was sharing data it collected during a clinical study. That was a laudable move, but made much easier by the non-profit nature of the research organization involved. Here’s a sign that openness is spreading even to commercial research, as reported by The New York Times:

In an unusual move, a leading genetic testing company is putting genetic information from the people it has tested into the public domain, a move the company says could make a large trove of data available to researchers looking for genes linked to various diseases.

Read more on TechDirt.

Sorry, the comment form is closed at this time.